All articles by Manish Kumar
Manish Kumar
Sirius Medical secures scale-up funding to further advance its surgical marker navigation portfolio
World Cancer Day is a poignant reminder of the ongoing fight against cancer, and this milestone reflects Sirius Medical’s commitment to enhancing cancer care
Surmodics reports early clinical use of Pounce XL Thrombectomy System
The Pounce XL Thrombectomy System, which was cleared by the FDA in September 2024, targets vessels 5.5–10mm in diameter, typical of iliac and femoral arteries
BD mulling sale of life sciences division at $30bn
Activist investor Starboard Value after acquiring a stake in BD, is pushing the $72bn medical tech firm to sell its life sciences division
Glo2Facial launches RF Pro by Geneo United
The first and only radio frequency (RF) technology in the noninvasive facial device category
for use by licensed estheticians in the U.S.
Dxcover accelerates growth with new funding round and strengthens the leadership team
– New capital raise from existing investors, as well as new investors, Macmillan Cancer Support and Maven Capital Partners, to drive innovation and commercial opportunities
Roche’s PATHWAY test gets FDA approval to identify HER2-ultralow breast cancer patients
Enhertu, a HER2-directed ADC by Daiichi Sankyo and AstraZeneca, was approved by the FDA recently for treating unresectable or metastatic HR-positive, HER2-low, or HER2-ultralow breast cancer
C2N Diagnostics’ PrecivityAD2 test improves AD diagnosis, finds study
The test improved amyloid plaque detection, boosting AD diagnosis accuracy and leading to better clinical care, including adjusted medication plans and additional testing
C the Signs announces investment from Khosla Ventures to advance AI-powered early cancer detection
Following success across the UK’s National Health Service identifying breast, ovarian, and colorectal cancers years earlier than traditional methods, Khosla invests to bring to the US
Alvogen issues voluntary nationwide recall for one lot of Fentanyl Transdermal System 25 mcg/h
This lot of Fentanyl Transdermal System was distributed nationwide to the pharmacy and patient level
Neuronoff secures US government funding for neuromodulation technologies
The DOD has recommended $1.73m for a neurogenic bladder RCT, while NIH has awarded $3.2m for preclinical overactive bladder research